Tag: Health Sciences Award

JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Published on by WSA Awards

Dr. JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Associate Professor at JSS College of Pharmacy, Ooty JSS Acedemy of higher education and research, Mysuru, India

Dr. Jawahar Natarajan is an esteemed Associate Professor in the Department of Pharmaceutics at JSS College of Pharmacy, Ooty, with over 22 years of experience in pharmaceutical education and research. He earned his Ph.D. from JSS University in 2014, specializing in drug delivery systems, and holds an M. Pharm in Pharmaceutics. Dr. Natarajan has guided several Ph.D. scholars, successfully mentoring projects focused on advanced drug delivery technologies for neurological and oncological diseases. His extensive research contributions include numerous M. Pharm projects, demonstrating his commitment to innovative solutions in pharmaceuticals. In addition to his academic responsibilities, he has also undertaken a Diploma in Drug Regulatory Affairs and participated in online courses to enhance his expertise. His dedication to advancing pharmaceutical sciences makes him a prominent figure in his field, contributing significantly to both academic and industry-related advancements.

Profile

Education

Dr. Jawahar Natarajan completed his Ph.D. in Pharmaceutics at JSS College of Pharmacy, Ooty, under JSS University, Mysore, in 2014. He also holds a Master of Pharmacy (M.Pharm) degree in Pharmaceutics from K.M. College of Pharmacy, Madurai, completed in 2002 with a commendable 69% score. His academic journey began with a Bachelor of Pharmacy (B.Pharm) from A.K. College of Pharmacy, Krishnan Kovil, in 1999, where he graduated with 61%. In addition to his formal degrees, Dr. Natarajan pursued a Diploma in Drug Regulatory Affairs (DDRA) at the Institute of Pharmaceutical Education and Research, Pune, in 2010, achieving an excellent grade. He further enhanced his knowledge through an online certification course in Industrial Pharmacy from HNB Garhwal University in 2021, scoring 68%. Dr. Natarajan’s diverse educational background reflects his commitment to the field of pharmaceutical sciences, particularly in drug delivery systems.

Professional Experience

Dr. Jawahar Natarajan is an esteemed Associate Professor at the Department of Pharmaceutics, JSS College of Pharmacy in Ooty, affiliated with the JSS Academy of Higher Education and Research. With over 22 years of experience in academia, he has held various teaching positions at reputable institutions, including S. Chattanatha Karayalar College of Pharmacy and Swamy Vivekananda College of Pharmacy. Since joining JSS College of Pharmacy in 2007, Dr. Natarajan has progressed from Lecturer to Assistant Professor and then to his current role as Associate Professor, showcasing his commitment to pharmaceutical education and research. He has guided numerous Ph.D. scholars and M. Pharm students, focusing on innovative drug delivery systems, particularly in the areas of nanoparticle formulation and cancer therapeutics. Dr. Natarajan’s expertise is further complemented by his involvement in curriculum development and regulatory affairs, contributing significantly to the growth of pharmacy education in India.

Research Interest

Dr. Jawahar Natarajan’s research interests are primarily focused on drug delivery systems, particularly in the development of innovative formulations to enhance the bioavailability and therapeutic efficacy of pharmaceutical compounds. His work includes investigating novel nanocarrier systems, such as solid lipid nanoparticles, nanostructured lipid carriers, and liposomes, aimed at improving targeted delivery and minimizing side effects. Dr. Natarajan is also engaged in exploring the use of biocompatible and biodegradable materials in drug formulation, contributing to advancements in personalized medicine. His ongoing research projects involve the bio-directed green synthesis of nanoparticles and the modulation of metabolic pathways for cancer treatment, demonstrating his commitment to addressing significant health challenges. Additionally, Dr. Natarajan actively mentors Ph.D. scholars and oversees various M. Pharm projects, fostering the next generation of pharmaceutical researchers while promoting innovative solutions in the field of pharmaceutics.

Research Skills

Dr. Jawahar Natarajan possesses a diverse array of research skills, primarily focused on drug delivery systems within the field of pharmaceutics. With over 22 years of experience, he has developed a profound expertise in formulating nanoparticles, liposomes, and nanostructured lipid carriers, enhancing the bioavailability of various therapeutic agents. His proficiency extends to guiding Ph.D. scholars and M. Pharm students, where he has successfully supervised numerous research projects that explore innovative drug delivery methodologies. Dr. Natarajan is adept at utilizing advanced analytical techniques, including characterization methods for nanomaterials and pharmacokinetic evaluations. His commitment to research is reflected in his contributions to peer-reviewed journals and active participation in conferences. Additionally, his skills in regulatory affairs ensure compliance with industry standards, bolstering the translation of research findings into practical applications. Overall, Dr. Natarajan’s comprehensive skill set underpins his significant contributions to pharmaceutical research and education.

Award and Recognition

Dr. Jawahar Natarajan, an esteemed Associate Professor at JSS College of Pharmacy, has garnered significant recognition for his contributions to the field of pharmaceutics and drug delivery systems. With over 22 years of academic experience, he has successfully guided numerous Ph.D. and M. Pharm. scholars, leading innovative research in targeted drug delivery and nanotechnology. His commitment to excellence is reflected in his impactful publications in reputable journals and presentations at national and international conferences. Dr. Natarajan has also played a pivotal role in enhancing pharmaceutical education through his involvement in curriculum development and academic committees. His dedication to advancing the field has earned him accolades from peers and institutions alike, establishing him as a respected figure in pharmaceutical sciences. Furthermore, his ongoing research continues to contribute to the advancement of healthcare solutions, solidifying his reputation as a leader in pharmaceutical research and education.

Conclusion

Jawahar N. possesses a strong foundation for the Research for Excellence in Research award through his extensive experience, solid educational background, and commitment to research in drug delivery systems. By enhancing his publication record and seeking collaborative and funding opportunities, he could further bolster his candidacy. His dedication to mentoring students and contributing to innovative projects in pharmaceutics makes him a commendable nominee for this prestigious recognition. Overall, Jawahar’s contributions to the field are noteworthy, and with slight adjustments and enhancements in his research visibility and collaboration efforts, he is well-positioned to excel in his future endeavors.

Publication Top Notes
  1. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review
    • Authors: N Jawahar, S Meyyanathan
    • Year: 2012
    • Journal: International Journal of Health & Allied Sciences
    • Volume/Issue/Page: 1 (4), 217-217
  2. Development of buccal tablets for curcumin using Anacardium occidentale gum
    • Authors: K Gowthamarajan, N Jawahar, P Wake, K Jain, S Sood
    • Year: 2012
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 88 (4), 1177-1183
  3. Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using natural polymer
    • Authors: GNK Ganesh, R Sureshkumar, N Jawahar, V Senthil, DN Venkatesh, …
    • Year: 2010
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 2 (6), 360
  4. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers
    • Authors: N Jawahar, PK Hingarh, R Arun, J Selvaraj, A Anbarasan, …
    • Year: 2018
    • Journal: International Journal of Biological Macromolecules
    • Volume/Issue/Page: 110, 269-275
  5. Solid lipid nanoparticles for oral delivery of poorly soluble drugs
    • Authors: N Jawahar, SN Meyyanathan, G Reddy, S Sood
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (7), 1848
  6. Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability
    • Authors: S Sood, N Jawahar, K Jain, K Gowthamarajan, S Nainar Meyyanathan
    • Year: 2013
    • Journal: Current Nanoscience
    • Volume/Issue/Page: 9 (1), 26-34
  7. Anti–arthritic activity of bark extracts of Alangium salviifolium Wang
    • Authors: S Jubie, N Jawahar, R Koshy, B Gowramma, V Murugan, B Suresh
    • Year: 2008
    • Journal: Rasayan J. Chem
    • Volume/Issue/Page: 1 (3), 433-436
  8. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent
    • Authors: N Jawahar, T Eagappanath, N Venkatesh, S Jubie, MK Samanta
    • Year: 2009
    • Journal: International Journal of Pharm Tech Research
    • Volume/Issue/Page: 1 (2), 390-393
  9. Nanoparticles: A novel pulmonary drug delivery system for tuberculosis
    • Authors: N Jawahar, G Reddy
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (8), 1901
  10. Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives
    • Authors: S Jubie, B Gowramma, KM Nitin, N Jawahar, R Kalirajan, S Gomathy, …
    • Year: 2009
    • Journal: Indian Journal of Pharmaceutical Sciences
    • Volume/Issue/Page: 1 (1), 32-38

 

 

 

 

Mona Arafa | Health Professions | Best Researcher Award

Published on by WSA Awards

Assoc Prof Dr. Mona Arafa | Health Professions | Best Researcher Award

Faculty of Pharmacy at University of Tabuk, Saudi Arabia.

Dr. Mona Farouk Mahmoud Arafa is an accomplished Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She earned her Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, focusing on enhancing oral bioavailability through drug crystalline structure modification. With a solid foundation in pharmacy, she has progressed through various academic roles, from Demonstrator to Associate Professor, and actively contributes to departmental committees and quality assurance initiatives. Dr. Arafa’s research interests center on the formulation and evaluation of microemulsions, niosomes, and colloidal systems to improve transdermal drug delivery and oral absorption. She has authored numerous publications in reputable journals and has extensive experience with advanced techniques such as high-performance liquid chromatography and differential scanning calorimetry. Dr. Arafa is committed to advancing pharmaceutical sciences and education, having participated in various training programs to enhance her teaching and research capabilities.

Profile:

Education

Dr. Mona Farouk Mahmoud Arafa holds an impressive educational background in the field of pharmacy and pharmaceutical technology. She earned her Bachelor’s degree in Pharmacy from the University of Tanta, Egypt, in 2009, graduating with a general grade of “Excellent with Honor.” She then pursued her Master’s degree in Pharmaceutical Technology at the same institution, completing her thesis on the optimization of colloidal carriers for the simultaneous transdermal delivery of two drugs in 2013. Dr. Arafa continued her academic journey by obtaining her Ph.D. in Pharmaceutical Technology in 2017, also from the University of Tanta. Her doctoral research focused on the investigation of drug crystalline structure modification as a tool for enhancing oral bioavailability. This strong educational foundation has equipped Dr. Arafa with the knowledge and expertise necessary to excel in her role as an associate professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia.

Professional Experience

Dr. Mona Farouk Mahmoud Arafa is an accomplished academic and researcher in the field of Pharmaceutical Technology, currently serving as an Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She holds a Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, where her research focused on enhancing oral bioavailability through drug crystalline structure modification. Dr. Arafa has progressively advanced through various academic ranks, starting as a Demonstrator and rising to her current position. Her administrative roles include membership in departmental councils, student affairs committees, and quality assurance units. With a strong emphasis on research, Dr. Arafa has authored numerous publications in esteemed journals, contributing to advancements in drug delivery systems, microemulsions, and transdermal formulations. Her expertise is complemented by active participation in training programs and workshops, enhancing her skills in crisis management, international publishing, and digital transformation within higher education.

Research Interest

Dr. Mona Farouk Mahmoud Arafa’s research interests lie in the field of pharmaceutical technology, with a particular focus on enhancing drug delivery systems. Her work involves the formulation, characterization, and evaluation of innovative colloidal carriers, including microemulsions and niosomes, aimed at improving transdermal drug delivery. Dr. Arafa employs advanced analytical techniques such as differential scanning calorimetry, X-ray powder diffraction, and Fourier transform infrared spectroscopy to study the modulation of crystalline structures in drugs. This research is pivotal in understanding how drug interactions with various co-processors can enhance oral bioavailability and absorption. Additionally, she investigates the applications of novel excipients and co-crystal formations to optimize drug dissolution rates. Through her comprehensive approach, Dr. Arafa contributes significantly to the development of advanced pharmaceutical formulations, striving to address challenges in drug delivery and improve therapeutic outcomes for patients.

Research Skills

Dr. Mona Farouk Mahmoud Arafa possesses a robust set of research skills that significantly contribute to her expertise in pharmaceutical technology. Her proficiency in formulating, characterizing, and evaluating various drug delivery systems, including microemulsions and niosomes, showcases her ability to innovate in the field. Dr. Arafa is adept in employing advanced analytical techniques, such as high-performance liquid chromatography, differential scanning calorimetry, and X-ray powder diffraction, to assess drug crystalline structures and enhance oral bioavailability. Her extensive publication record in peer-reviewed journals highlights her capability to conduct rigorous research, analyze complex data, and communicate findings effectively. Additionally, her experience in collaborative research and training programs underscores her commitment to academic excellence and professional development. Dr. Arafa’s skill set not only emphasizes her technical expertise but also reflects her dedication to advancing pharmaceutical sciences and improving patient outcomes through innovative drug delivery systems.

Award and Recognition

Dr. Mona Farouk Mahmoud Arafa, an esteemed Associate Professor in the Pharmaceutics Department at Tabuk University, has received numerous awards and recognitions for her exceptional contributions to pharmaceutical technology. Her groundbreaking research, particularly in the enhancement of oral bioavailability and transdermal drug delivery systems, has been published in high-impact journals, earning her a respected reputation in the academic community. Dr. Arafa’s innovative work on drug crystalline structure modification and the development of novel colloidal carriers has not only advanced scientific understanding but also significantly impacted pharmaceutical practices. She has been actively involved in training programs and workshops, fostering a culture of excellence in education and research. Additionally, her leadership roles within various academic committees reflect her commitment to quality assurance in higher education. Dr. Arafa’s dedication to her field, combined with her extensive research output, underscores her eligibility for recognition as a leading researcher in the pharmaceutical sciences.

Conclusion

Dr. Mona Farouk Mahmoud Arafa is a highly qualified candidate for the Best Researcher Award, exemplifying dedication to research, education, and academic leadership. Her extensive publications, innovative research in drug delivery systems, and administrative roles underscore her commitment to advancing pharmaceutical sciences. By addressing areas for improvement, particularly in networking and public engagement, Dr. Arafa can further elevate her contributions to the field and enhance her influence as a researcher and educator. Recognizing her with this award would not only honor her achievements but also inspire others in the academic community.

Publication Top Notes

  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: SA El-Gizawy, MA Osman, MF Arafa, GM El Maghraby
    • Year: 2015
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2016
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: RK Eid, DS Ashour, EA Essa, GM El Maghraby, MF Arafa
    • Year: 2020
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2018
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2017
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: GM El Maghraby, MF Arafa, MA Osman
    • Year: 2014
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: HF Marei, MF Arafa, EA Essa, GM El Maghraby
    • Year: 2021
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: DA Elmehy, MA Hasby Saad, GM El Maghraby, MF Arafa, NA Soliman, …
    • Year: 2021

 

Faezeh Zakerinasab | Health Professions | Women Researcher Award

Published on by WSA Awards

Dr. Faezeh Zakerinasab | Health Professions | Women Researcher Award

Dr. Faezeh Zakerinasab, Mashhad university of medical Sci, Iran

Dr. Faezeh Zakerinasab is a researcher and academic affiliated with Mashhad University of Medical Sciences in Iran. With a focus on [specific field or specialty, if known], Dr. Zakerinasab has contributed to various studies and publications that enhance the understanding of [mention specific topics or areas of research]. She is dedicated to advancing medical science and improving healthcare outcomes through her research and teaching efforts.

Profile:

 

Education:

Dr. Faezeh Zakerinasab is a physician and healthcare management professional currently affiliated with Mashhad University of Medical Sciences in Iran. She earned her Doctor of Medicine (MD) from Mashhad University of Medical Sciences, graduating in 2022. Following her medical training, she pursued an MBA in Healthcare Management at Ferdowsi College of Economic & Administrative Science, expected to complete in 2024. Dr. Zakerinasab is committed to integrating medical expertise with effective healthcare administration to improve patient outcomes and healthcare delivery.

Voluntary Experiences:

Dr. Faezeh Zakerinasab has actively contributed to the COVID-19 vaccination project in Mashhad, Iran, serving as a general physician and executive manager. She participated voluntarily beyond her academic program in the obstetrics and gynecology clinic to deepen her understanding of women’s health issues. During her externships and internships, Dr. Zakerinasab conducted free blood sugar screenings, nutritional counseling, and blood pressure testing at Mellat Park in Mashhad, showcasing her commitment to community health and education while studying basic medical sciences.

Certificates:

Dr. Faezeh Zakerinasab is a physician from Mashhad University of Medical Sciences, Iran, with specialized training in various advanced laboratory techniques. She has obtained certifications in cell culture, Western blotting, real-time PCR, and the application of imaging techniques. Additionally, Dr. Zakerinasab is skilled in oocyte and embryo vitrification, bioinformatics, and reproductive biology. Her diverse skill set enhances her ability to contribute to research and practice in reproductive health and related fields.

Publication Top Notes:

Risk of Neonatal Outcomes Associated with COVID-19 Infection during Pregnancy: A Retrospective Cohort Study

Authors: M Mahmoudinia, T Sadeghi, N Sheikhi, M Niknazar, F Zakerinasab

Journal: International Journal of Pediatrics

Year: 2023

Volume: 11

Issue: 7

Pages: 18027-18036

Live Birth after Cleavage-Stage versus Blastocyst-Stage Embryo Transfer in Assisted Reproductive Technology: A Randomised Controlled Study

Authors: M Mahmoudinia, B Sovizi, SMR Ebadi, F Zakerinasab, T Sadeghi, …

Journal: International Journal of Fertility and Sterility

Year: 2024

Volume: 18

Supplement: 1

Pages: 10-16

BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis

Authors: F Zakerinasab, Q Behfar, R Parsaee, RH Zadeh, E Foroughi, A Amirbeik, …

Journal: BMC Genomic Data

Year: 2024

Volume: 25

Issue: 1

Page: 13

Frequency of Skin Diseases in Dermatology Consultations: Descriptive Research

Authors: FZN Seddigheh Hossein-Nejad, Yalda Nahidi, Shatila Torabi, Lida Jarahi, …

Journal: Turkiye Klinikleri Journal of Dermatology

Year: 2023

Volume: 23

Issue: 2

The effect of intravenous Calcium gluconate on the prevention of Ovarian Hyperstimulation Syndrome. (A randomized clinical trial)

Authors: M Lotfalizadeh, N Khadem, M Mahmoudinia, P Faraji, F Zakerinasab, …

Journal: Journal of Gynecology Obstetrics and Human Reproduction

Year: 2024

Article ID: 102850

The effects of growth hormone supplementation in poor ovarian responders undergoing in vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis

Authors: F Zakerinasab, Q Behfar, R Parsaee, FA Mojeni, A Ansari, N Deravi, …

Journal: Turk J Obstet Gynecol

Year: 2024

Volume: 21

Issue: 3

Pages: 208-218

Live birth after cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology: a randomised controlled study

Authors: M Maliheh, B Souizi, SMR Ebadi, F Zakerinasab, T Sadeghi, …

Journal: International Journal of Fertility & Sterility

Year: 2024

Volume: 18

Supplement: 1

Page: 10

Association between Maternal smoking during pregnancy and risk of ADHD: a systematic review and meta-analysis of prospective cohort studies

Authors: F Zakerinasab

Platform: OSF

Year: 2023

The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: A systematic review and meta-analysis of randomized controlled trials

Authors: RK Faezeh Zakerinasab, Qumars Behfar, Reza Parsaee, Fariba Arbab Mojeni, …

Journal: Obstetrics and Gynecology International

Year: 2023

Obstetric Patients with Coronavirus Disease: Symptoms and Critical Illness & Mortality in 2019 (COVID-19) Infection in Imam Reza’s Hospital

Authors: AM Faezeh Zakerinasab, Jamshid Jamali, Tahereh Sadeghi, Nafiseh Jahanpak, …

Journal: Journal of Midwifery & Reproductive Health

Year: 2023

Effect of co-administration of gonadotropins and letrozole during ovarian stimulation on IVF outcome for poor responders: a systematic review and meta-analysis of randomized controlled trials

Authors: F Zakerinasab*, Qumars Behfar, Reza Parsaee, Mahdis Sadat Miri, …

Journal: [Journal Name Not Provided]

Year: [Year Not Provided]

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79